Health
7 important health stories this week you simply can't miss
![7 important health stories this week you simply can't miss](https://static.foxnews.com/foxnews.com/content/uploads/2024/06/weekend-recap-split.jpg)
Every day of the week, Fox News Digital publishes a range of health and wellness pieces to keep you up-to-date on medical research, new medications, mental health trends, success stories and more.
In case you missed them, here are a few of the biggest health stories from the past week.
As always, you can see a full list of recent health pieces at http://www.foxnews/health.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
1. FDA tells COVID vaccine makers to update their fall shots
The U.S. Food and Drug Administration recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target the KP.2 strain of the JN.1 variant.
Dr. Marc Siegel shared insights on the risks as this variant grows more prominent. Click here to get the story.
“It makes sense to target the KP.2 strain because it is becoming the predominant strain — it is surging in California and will spread across the country,” Siegel told Fox News Digital. (iStock)
2. Expert offers 7 tips to soothe sunburned skin
If not treated properly, sunburn can lead to severe skin damage and increase the risk of skin cancer, experts warn.
Angela Rosoff, a San Francisco-based wellness and beauty expert, shared some proven remedies to treat sun-damaged skin. Click here to get the story.
![Woman with sunburn](https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2024/06/1200/675/sunburned-woman.jpg?ve=1&tl=1)
More than one out of every three adults experienced a sunburn last year, according to a survey by the American Academy of Dermatology. (iStock)
3. Tiger mosquitoes blamed for spread of dengue fever
As dengue fever continues to spread throughout Europe, experts are naming an invasive mosquito species as the culprit.
CANCER NEARLY TOOK HIS LEG, BUT NEW JERSEY FATHER OF 6 WALKS AGAIN: ‘I SHOULDN’T BE HERE’
Infectious diseases experts weighed in on the level of risk and share prevention tips. Click here to get the story.
![Tiger mosquito](https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2024/06/1200/675/tiger-mosquito.jpg?ve=1&tl=1)
Tiger mosquitoes — the species Aedes albopictus — have spread into 13 EU countries, according to an alert from the European Centre for Disease Prevention and Control. (iStock)
4. Certain exercises could reverse Alzheimer’s, expert says
In her new book, “Reversing Alzheimer’s,” Dr. Heather Sandison, a renowned expert in dementia care, offered specific recommendations for the types of exercise that can benefit patients living with the disease.
“Exercise benefits several of the root causes of neurological disease,” she wrote. Click here to get the story.
![Weekend recap](https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2024/06/1200/675/weekend-recap-split.jpg?ve=1&tl=1)
Sunburn remedies, new COVID vaccines, anti-Alzheimer’s exercises and more important stories are covered here. (iStock)
5. Experts bust sunscreen myths
Some claims on social media about sun safety have led to a major misconception that sunscreen could cause skin cancer.
Dermatologists debunk these potentially dangerous myths. Click here to get the story.
![woman using sunscreen on a beach](https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2024/06/1200/675/iStock-1311504201.jpg?ve=1&tl=1)
Thirty-two percent of Americans believe that a tan makes people look better and healthier, according to the Orlando Health Cancer Institute study. (iStock)
6. New Alzheimer’s drug gets thumbs-up from FDA advisory committee
Donanemab, designed to treat mild cognitive impairment and other symptoms of early Alzheimer’s disease, was endorsed by a U.S. Food and Drug Administration advisory panel.
Here’s what that could mean for patients. Click here to get the story.
![Older woman taking pills](https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2024/06/1200/675/older-woman-pills.jpg?ve=1&tl=1)
Eli Lilly officials presented clinical trial results showing that the drug, donanemab, slowed cognitive and functional decline for people with mild cognitive impairment due to early stages of Alzheimer’s. (iStock)
7. FDA panel rejects MDMA-assisted therapies for PTSD
Many veterans’ hopes were dashed when an FDA advisory committee voted against the overall benefits of MDMA when used to treat PTSD.
Advocates and doctors discussed what this means for the future of psychedelic treatments. Click here to get the story.
![FDA sign next to a sad veteran](https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2024/06/1200/675/fda-vet-split.png?ve=1&tl=1)
“When I heard the verdict, all I could think about was the hopes of those veterans being dashed … and not having a solution for them,” one advocate said. (iStock)
![](https://newspub.live/wp-content/uploads/2022/03/np-logo.png)
Health
The Carnivore Diet: Is There Science Behind the Fad? | Woman's World
![The Carnivore Diet: Is There Science Behind the Fad? | Woman's World](https://www.womansworld.com/wp-content/uploads/2024/06/carnivore-diet.jpg)
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
Forgot your password?
Get back to the Sign In
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Health
For diabetes patients, inhaled insulin is shown just as effective as injections and pumps
![For diabetes patients, inhaled insulin is shown just as effective as injections and pumps](https://static.foxnews.com/foxnews.com/content/uploads/2024/06/diabetes-insulin-inhaler.jpg)
Most of the 38 million people living with diabetes in the U.S. use daily injections or insulin pumps to keep glucose at safe levels — but new research suggests that a third option could be just as effective.
In a study led by Dr. Irl B. Hirsch, M.D., medical director of the Diabetes Care Center of the University of Washington Medical Center, an inhaled form of insulin — similar to an asthma inhaler — worked just as well as injections or pumps to control type 1 diabetes.
The research was presented last week at the American Diabetes Association (ADA)’s 84th Scientific Sessions in Orlando, Florida.
EATING YOGURT COULD HELP PREVENT ONE COMMON DISEASE, ACCORDING TO THE FDA
The clinical trial tested a product called Afrezza, an inhaled insulin made by MannKind Corporation in California.
Afrezza, the only inhaled insulin on the market, has been available since getting FDA approval in June 2014.
An inhaled form of insulin worked just as well as injections or pumps to control type 1 diabetes in a recent study. (iStock/MannKind)
Benefits of a third option
“In those with type 1 diabetes, insulin is required for survival,” Hirsch told Fox News Digital in an interview.
“With continuous glucose sensing, glucose control has been dramatically improved — but not everyone reaches the target with multiple injections or pumps, and there are many pros and cons with each therapy,” he said.
EATING ONE TYPE OF FRUIT REGULARLY COULD REDUCE DIABETES RISK IN WOMEN, STUDY SUGGESTS: ‘INCREDIBLY HEALTHY’
With pumps, people must wear the device, which can lead to skin problems.
They also have to purchase extra accessories.
Blood glucose levels can also drop with exercise, Hirsch warned, which can be problematic.
![Afrezza inhaler](https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2024/06/1200/675/Inhaler.Insulin.jpg?ve=1&tl=1)
Afrezza, an inhaled insulin pictured here, is made by MannKind Corporation in California. (MannKind)
“Injections overall can be more convenient for some, but they don’t do as well as pump patients,” he said.
With Afrezza, the product is inhaled into the lungs before meals, and the fast-acting insulin minimizes the glucose spike often seen after eating, Hirsch noted.
“Patients with type 1 diabetes should consider this as another option for their mealtime insulin, and talk to their doctor about this choice.”
During the 17-week study, researchers evaluated the results of 141 adults who were assigned to either use the Afrezza inhaler or continue with traditional methods of injection or pump delivery.
At the 17-week mark, all participants switched to the inhaler for another 13 weeks.
![Dr. Irl B. Hirsch](https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2024/06/1200/675/Dr.-Irl-B.-Hirsch52.jpg?ve=1&tl=1)
Dr. Irl B. Hirsch, M.D., medical director of the Diabetes Care Center of the University of Washington Medical Center, led the new study. (MannKind)
All groups were assessed with continuous glucose monitoring at the start of the study, at 17 weeks and again at 30 weeks.
Among the inhaled insulin group, 30% of participants reached their target glucose levels (less than 7% blood sugar) compared to 17% of the people using injections and pumps.
There was no difference in hypoglycemia (low blood sugar) between the groups.
UTAH MOM FIGHTS FOR HER DAUGHTER’S ACCESS TO DISCONTINUED DIABETES MEDICATION: ‘LIFE-SAVING’
“In general, there was no difference in our primary endpoint, HbA1c, a reflection of average blood sugar,” Hirsch said.
“But that alone is misleading — many patients did better with their glucose control, while others did worse.”
![Afrezza inhaler](https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2024/06/1200/675/Afrezza-269-scaled.jpg?ve=1&tl=1)
With Afrezza, the product is inhaled into the lungs before meals, and the fast-acting insulin minimizes the glucose spike often seen after eating, a doctor said. (MannKind)
“The point is, inhaling insulin isn’t for everyone, but some did better than they did on their pumps.”
The people who saw the best results inhaled insulin between meals and at bedtime, Hirsch added.
At the end of the study, more than half of the participants said they would opt to stay on the inhaled insulin therapy.
“The biggest takeaway is that patients with type 1 diabetes should consider this as another option for their mealtime insulin, and talk to their doctor about this choice,” he recommended.
‘Adds value’
The American Diabetes Association acknowledged the promise of the study findings in an email to Fox News Digital.
“We look forward to our Scientific Sessions every year to see data like the INHALE-3 study’s findings, which have the potential to expand diabetes care,” Raveendhara Bannuru, M.D., PhD, the ADA’s vice president of medical affairs and quality improvement outcomes in Boston, Massachusetts, told Fox News Digital via email.
![diabetes CGM](https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2023/09/1200/675/iStock-1367251295.jpg?ve=1&tl=1)
“With continuous glucose sensing, glucose control has been dramatically improved,” a doctor told Fox News Digital. (iStock)
“We are hopeful for the continuous development of alternative insulin delivery methods that could offer options for people living with diabetes,” the group also said in the statement.
“The INHALE-3 trial demonstrated that inhaled insulin, combined with insulin degludec, effectively reduces A1c levels without increasing hypoglycemia or weight gain in people with type 1 diabetes. This adds value to the options in insulin therapy.”
Potential risks and limitations
While more people met their glycemic targets with Afrezza, some subjects saw worse readings when switching from usual methods to inhaled insulin — “potentially due to missing doses of inhaled insulin during the day and/or underdosing going into bedtime,” the researchers wrote.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“We didn’t see any concerns,” Hirsch said when asked about side effects.
“As expected, a few people coughed immediately when dosing their insulin, but no major concerns were seen and everyone continued on their inhaled insulin.”
![Insulin injection](https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2023/05/1200/675/insulin-injection.jpg?ve=1&tl=1)
“Not everyone reaches the target with multiple injections or pumps, and there are many pros and cons with each therapy,” a doctor said. (iStock)
The most common side effects noted in the study were hypoglycemia, cough and throat pain or irritation.
Afrezza has been linked to a risk of acute bronchospasm in patients with chronic lung disease, such as asthma or COPD, according to the manufacturer.
“Inhaling insulin isn’t for everyone, but some did better than they did on their pumps.”
Before starting Afrezza, patients should see a doctor for a physical examination and testing to measure lung function.
Patients who smoke or who recently quit smoking should not take the inhaled medication.
For more Health articles, visit www.foxnews/health
Fox News Digital reached out to MannKind requesting additional comment.
Health
Surgeon general declares firearm violence in America a public health crisis
![Surgeon general declares firearm violence in America a public health crisis](https://static.foxnews.com/foxnews.com/content/uploads/2024/06/GettyImages-1717037957-scaled-e1719315853750.jpg)
The United States surgeon general is declaring gun violence a national public health crisis.
Surgeon General Vivek Murthy issued an advisory on Tuesday stating that firearm-related violence and its immediate psychological ramifications on victims and bystanders has severely compromised public health.
“Today, for the first time in the history of our office, I am issuing a Surgeon General’s Advisory on firearm violence,” Murthy said in a video announcement. “It outlines the urgent threat firearm violence poses to the health and well-being of our country.”
SUPREME COURT UPHOLDS FEDERAL GUN BAN FOR THOSE UNDER DOMESTIC VIOLENCE RESTRAINING ORDERS
U.S. Surgeon General Dr. Vivek Murthy released a special advisory on firearm violence on Tuesday, calling gun-related incidents a public health crisis. (Nathan Congleton/NBC via Getty Images)
“As a doctor, I’ve seen the consequences of firearm violence up close and the lives of the patients that cared for over the years,” the surgeon general continued. “These are moms and dads, sons and daughters, all of whom were robbed of their physical and mental health by senseless acts of violence.”
The advisory states that 54% of adults in America have experienced a firearm-related incident. These experiences with firearm violence include individuals who have been threatened with a gun (21%), lost a family member in a gun-related death (19%), witnessed a shooting (17%), and been wounded by a firearm (4%).
The 54% figure also includes adults who have fired a gun in self-defense (4%). The gun-related death statistic includes those who committed suicide via firearm.
The report noted different demographics are affected in different ways by gun violence.
Black individuals suffer the highest rate of gun deaths. American Indians, Alaskan Natives, elderly white people, and military veterans are at the highest risk suicide by firearm.
“Beyond these precious lives that are lost to firearm violence, there are wider ripples of harm to those who are injured, who witnessed the incidents, who live in urban and rural communities where such violence takes place, and who constantly read and hear about firearm violence,” Murthy stated.
MARYLAND GOVERNOR SIGNS BIDEN-INSPIRED BILL ESTABLISHED ‘CENTER FOR FIREARM VIOLENCE PREVENTION’
![Vivek Murthy](https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2024/06/1200/675/GettyImages-1953493545-scaled-e1719314559178.jpg?ve=1&tl=1)
Murthy wrote in the report that the direct casualties of gun violence are compounded by psychological ramifications inflicted on victims and bystanders. (Tom Williams/CQ-Roll Call, Inc via Getty Images)
He added, “The collective trauma and fear that Americans are experiencing is contributing to the mental health challenges that we are facing today. Nearly 6 in 10 U.S. adults say they worry about a loved one being a victim of firearm violence.”
The public advisory on firearm-related violence is the first document of its kind released by the Surgeon General’s Office.
-
News1 week ago
Joe Biden, Barack Obama And Jimmy Kimmel Warn Of Another Donald Trump Term; Star-Filled L.A. Fundraiser Expected To Raise At Least $30 Million — Update
-
News1 week ago
It's easy to believe young voters could back Trump at young conservative conference
-
World1 week ago
Russia-Ukraine war: List of key events, day 842
-
World1 week ago
Protesters in Brussels march against right-wing ideology
-
World1 week ago
Swiss summit demands 'territorial integrity' of Ukraine
-
News1 week ago
A fast-moving wildfire spreads north of Los Angeles, forcing evacuations
-
Politics1 week ago
Judge rules Missouri abortion ban did not aim to impose lawmakers' religious views on others
-
World1 week ago
Al-Qaeda affiliate claims responsibility for June attack in Burkina Faso